Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Gnosis Contributes to FASEB Conference on Vitamin K - Nutraceuticals World
Market Updates

Gnosis Contributes to FASEB Conference on Vitamin K

Gnosis, Desio, Italy, was a proud partner of the FASEB (Federation of American Societies for Experimental Biology) Conference on Vitamin K – Molecular, Structural & Clinical Aspects of Vitamin K and Vitamin K-Dependent Proteins, held on July 13 in Itasca, IL.

The company stated that this conference provided opportunities to discuss in depth research, scientific updates and new directions for future applications with vitamin K. Key areas of discussion included:

·       Emerging aspects of vitamin K biochemistry such as metabolic and anti-inflammatory roles
·       Current research on vitamin K metabolism and its unique actions both from basic and clinical research perspectives
·       New developments in emerging roles for vitamin K-dependent proteins in managing clinical conditions such as CVD, osteoarthritis, and chronic kidney disease

Clinicians, epidemiologists, basic and nutrition scientists and governmental policy makers provided a forum for the exchange of new knowledge about vitamin K that spanned from basic research to a wide variety of clinical applications to facilitate new collaborations and areas of novel research.

Gnosis is one of the main producers of vitamin K2 as menaquinone-7 branded as VitaMK7 and has more than 10 years of manufacturing experience.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters